Join this Webinar:
https://webstreamlive.com/Insightwebinar211117/registration/

會議重點如下:

1. Management of Male LUTS (男性下尿路症狀的管理)
   • Evolving medical treatment paradigm in Male LUTS. (男性下尿路症狀藥物治療介入範例)
   • Prostate Surgical interventions. (前列腺手術的介入時機)
2. Management of OAB (膀胱過動症的管理)
   • BELIEVE study – persistence of mirabegron in OAB patients. (BELIEVE研究結果-談Mirabegron治療對OAB患者的持久性)
   • Mirabegron in elderly patients – 12 wk Japanese post-marketing study. (Mirabegron在老年患者的表現-談日本上市後為期12週的研究結果)
   • The therapeutic adding effect of mirabegron 50 mg in Asian OAB patients after initial treatment of mirabegron 25 mg.
     (Mirabegron的追加劑量治療效果-以Mirabegron 25mg作為起始劑量後追加至50mg在亞洲OAB患者的研究結果)
3. ICI guideline on incontinence. (國際尿失禁諮詢專家-International Consultation Incontinence談尿失禁防治的看法)
4. Urinary Retention in Women (女性尿滯留)
   • Concept and pathophysiology (談女性尿滯留的概念和病理生理學)
   • Medical and surgical treatment (談女性尿滯留的藥物和手術治療)
5. Unsuccessful surgery for SUI (病例討論: 應力性尿失禁不成功的手術)